Trial Profile
Effect of Detemir and Sitagliptin on Blood Glucose Control in Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Sitagliptin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes
- 29 Jun 2010 Results were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 04 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.